Impact of beating heart left atrial ablation on left-sided heart mechanics  by Ota, Takeyoshi et al.
I
h
T
M
Evolving Technology Ota et al
9
ETmpact of beating heart left atrial ablation on left-sided
eart mechanics
akeyoshi Ota, MD, PhDa, David Schwartzman, MDb, David Francischelli, MSc, Douglas A. Hettrick, PhDc, and
arco A. Zenati, MDa
O
t
a
t
w
M
c
a
i
m
c
a
i
R
i
f
v
i
a
C
h
a
i
A
m
A
t
A
m
t
s
n
c
m
hFrom the Division of Cardiac Surgerya and
Cardiovascular Institute,b University of
Pittsburgh, Pittsburgh, Pa; and Medtronic,
Inc,c Minneapolis, Minn.
David Francischelli reports that he is an
employee of Medtronic, the manufacturer
of the ablation tool used in this study, an
equity owner of Medtronic, and the inven-
tor of patents related to the ablation device
with rights assigned to Medtronic. Douglas
Hettrick is an employee of Medtronic.
David Schwartzman reports consulting fees
and grant support from Medtronic. Marco
Zenati reports grant support from
Medtronic. This study was supported in
part by Medtronic.
Received for publication Dec 4, 2006; re-
visions received March 29, 2007; accepted
for publication April 9, 2007.
Address for reprints: Marco A. Zenati, MD,
Division of Cardiac Surgery, University of
Pittsburgh, 200 Lothrop St, PUH C-700,
Pittsburgh, PA 15213-2582 (E-mail:
zenatim@upmc.edu).
J Thorac Cardiovasc Surg 2007;134:982-8
0022-5223/$32.00
Copyright © 2007 by The American Asso-
ciation for Thoracic Surgerya
doi:10.1016/j.jtcvs.2007.04.063
82 The Journal of Thoracic and Cardiobjective: The cut-and-sew Cox–Maze procedure is the gold standard for surgical
reatment of atrial fibrillation, but it is associated with long-term impairment of left
trial mechanical function. We developed a bipolar, irrigated radiofrequency abla-
ion device. We hypothesized that beating heart radiofrequency left atrial ablation
ould result in minimal acute changes in left atrial hemodynamics.
ethods: Six healthy subjects were studied. Combination pressure-conductance
atheters were inserted into the left atrium and ventricle. With the use of the device,
trial ablation was performed on the beating heart without cardiopulmonary bypass,
ncluding electrical isolation of the posterior left atrium and atrial appendage
yocardium. Simultaneous left-sided heart pressure–volume and intracardiac echo-
ardiography data were acquired before ablation, after left atrial appendage ablation
lone, and after all ablation (with and without appendage occlusion). The derived
ndices of left-sided heart mechanical function were examined.
esults: Relative to baseline, no significant diminishment in pressure–volume or
ntracardiac echocardiography-derived indices of global left-sided heart mechanical
unction were observed after ablation, with or without appendage occlusion. Mitral
alve morphology and function were not significantly altered. A significant dimin-
shment of atrial appendage systolic flow was noted after appendage ablation in
ssociation with spontaneous echocardiographic contrast in this region.
onclusions: In this model, ablation does not seem to compromise global left-sided
eart mechanical function. However, these findings mask regional diminishment in
trial appendage systolic function. This observation demonstrates that electrical
solation of the appendage should be accompanied by its occlusion or excision.
ppendage occlusion after ablation does not seem to compromise left-sided heart
echanical function.
n ideal treatment for atrial fibrillation (AF) should achieve both restoration and
maintenance of sinus rhythm and recovery of biatrial contractile function. In
addition, an integral component of any therapeutic approach for AF should be
he reduction of thromboembolic risk primarily targeting the left atrial (LA) appendage.
s operative atrial ablation intended to cure or prevent AF progresses toward the
ainstream, questions have appropriately been raised as to the possibility that this
echnique may have detrimental effects. Apart from prolongation of a concomitant
urgical procedure, such effects could potentially include mechanical, intrinsic cardiac
eurologic, and/or humoral impairment. For example, evaluation of atrial function after
ut-and-sew Maze III surgery indicated that diminishment of LA mechanical function
ay result from the surgical lesions and tissue excision.1,2
Unlike in cut-and-sew Maze III surgery, recent advances in ablation technology
ave permitted the deployment of lesions in the beating heart and with less
triotomy.2 In addition, expanding insight into the atrial electrophysiologic substrate
vascular Surgery ● October 2007
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ETas led to a progressive reduction in ablation territory rel-
tive to that of classic Maze surgery.2 Each of these ele-
ents has the potential to influence the impact of the sur-
ery on cardiac mechanical function.
In the present study, we sought to assess the impact of
A ablation on left-sided heart mechanical function using a
orcine model in which a typical contemporary lesion set
as deployed in a beating heart.
aterials and Methods
nimals
ix healthy Duroc cross female pigs (weight 36  13 kg)
ormed the study cohort. We and others previously dem-
nstrated that atrial chamber dimensions, blood flow ve-
ocities, and wall thicknesses are similar to those of a
uman adult.3,4 All animals received humane care in a
acility sanctioned by the Council on Accreditation of the
ssociation for Assessment and Accreditation of Labo-
atory Animal Care, in accordance with the “Guide for
he Care and Use of Laboratory Animals” published by
he National Institutes of Health (publication 85-23, re-
ised 1985). The study protocol was approved by the
nstitutional Animal Care and Use Committee of the
niversity of Pittsburgh.
perative Technique
nimals were premedicated with intramuscular ketamine
nd inhaled isoflurane before endotracheal intubation. Once
he animals were intubated, a surgical plane of anesthesia
as achieved and maintained with isoflurane 1% to 5%
nspired. Arterial blood pressure, blood gases, and serum
lectrolytes were monitored serially. Each animal was sys-
emically anticoagulated (heparin, adjusted for body
eight) for the duration of the procedure. For insertion of
iagnostic catheters, endocardial access to the right atrium
as gained through a right femoral venipuncture, to the LA
ubsequently through an atrial transseptal puncture, and to
he left ventricle (LV) through a carotid arteriotomy and
etrograde transaortic passage. For ablation, epicardial ac-
ess to the LA was gained through median sternotomy and
ericardiotomy, and endocardial access was gained through
ocal atriotomies (see below). Some dissection in the pos-
Abbreviations and Acronyms
AF  atrial fibrillation
ICE  intracardiac echocardiography
LA  left atrial
LAA left atrial appendage
LV  left ventricle
RF  radiofrequencyerior mediastinum was necessary to create sufficient access l
The Journal of Thoracicor the ablation device; this required approximately 15
inutes per animal. At the completion of the experiment,
ach animal was euthanized while under deep anesthesia
sing an injection of potassium chloride.
blation
Device. Ablation was performed using a commercial
ipolar device (Cardioblate BP2, Medtronic Inc, Minneap-
lis, Minn).5 The device was composed of 2 stainless steel
lectrodes, arrayed as cathode and anode on opposing jaws
f a clamp-morphology skeleton, and embedded in a porous
olymer through which room-temperature normal saline
as irrigated at a rate of 4 mL/min. The device was coupled
o a commercial radiofrequency (RF) energy generator
Cardioblate, Medtronic Inc) from which real-time (updated
very 200 ms) impedance, power, lesion duration, and cu-
ulative delivered energy data were obtained. The genera-
or used a proprietary algorithm that titrated power, assessed
esion transmurality based on changes in impedance, and
ignaled the user when the lesion was completely
ransmural.
Lesion deployment and assessment. In each animal,
he same lesion set was deployed in the beating heart
ithout cardiopulmonary bypass (Figure 1). Encircling
igure 1. Ablation lesions, encircling lesions (dashed circles),
nd linear lesions (dashed lines, A-C). Approximate atriotomy
ites (●) required for access of 1 of the jaws of the ablation
evice during deployment of linear lesions (see text). Approxi-
ate sites () of pacing to assess for exit conduction block after
ncircling lesions (see text). LAA, Left atrial appendage; LPV, left
ulmonary veins; RPV, right pulmonary veins; MV, mitral valve.esions (appendage and pulmonary veins) were applied
and Cardiovascular Surgery ● Volume 134, Number 4 983
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ETy clamping the epicardium only. Linear lesions were
pplied with jaws located contiguously, 1 endocardial
nd 1 epicardial, after access was gained through focal
triotomies (Figure 1): lesions B (except 1 animal; see
elow) and C were each performed with a single RF
pplication; because of limited access, lesion A was
erformed in 2 adjacent RF applications, during which
he jaws of the device were oriented in opposite direc-
ions through a purse-string access. Note that the path of
esion C was chosen to avoid the portion of the circum-
ex coronary proximal to obtuse marginal branches; in
ll pigs, the coronary artery distribution was right coro-
ary artery dominant. The left atrial appendage (LAA)
as not excised. The order of lesion application was the
ame in each animal, with the LAA encircling lesion first,
ollowed by left then right pulmonary vein encircling
esions, and then linear lesions B, A, and C.
Immediately after lesion deployment, assessment of
lectrical conduction across the encircling lesions was
erformed by unipolar (7F, 2-mm length passive fixation
athode; noncardiac intrathoracic anode) epicardial pac-
ng of myocardium subtended by each of the encircling
esions after each RF application at a cycle length 100 ms
ess than sinus and an output of 20 mA (Figure 1).
onduction (as defined by acceleration of the ventricular
ycle length to that of pacing) from each of these same
erritories was demonstrated at baseline. Exit conduction
lock was defined by absence of this response. No as-
essment of conduction across the linear lesions was
erformed.
84 The Journal of Thoracic and Cardiovascular Surgery ● Octovaluation of Left-sided Heart Mechanics
he following 2 techniques were used:
1. Pressure–volume analysis: The utility of using con-
ductance to assess time-varying changes in global
cardiac chamber volumes has been described in de-
tail.6 Before ablation, 2 commercial duodecapolar
conductance catheters, each incorporating a pressure
sensor (CD Leycom, Inc, Zoetermeer, The Nether-
lands), were inserted into the heart: 1 into the LV and
1 into the LA. Each catheter insertion was guided by
intracardiac echocardiography (ICE; see below) to
ensure that appropriate positioning (defined by: i. all
electrodes located in the chamber and ii. catheters
location approximately midcavity, with no endocar-
dial contact) was achieved. Subsequently, in each
animal ICE was used to monitor catheter positions to
ensure positional constancy throughout the experi-
mental protocol (see below). Conductance data from
each catheter were collected simultaneously, as was
pressure, with 2 commercial acquisition systems
(CFL-512, CD Leycom, Inc) using unique stimula-
tion frequencies to avoid interference. Data from
each system were analyzed using investigational soft-
ware (Conduct NT, CD Leycom, Inc). Blood resis-
tivity was measured at baseline and at the end of the
experimental protocol. Data were obtained in stable
state and during transient manual constriction of the
inferior caval vein using a surgical tape; the latter
was used for calculations of LA and LV end-systolic
Figure 2. Typical examples of passive
(no perturbation; left) and active (infe-
rior caval constriction; right) LA (top
row) and LV (bottom row) pressure (Y
axis, in millimeters of mercury)-volume
(X axis, in milliliters) relationships.
The LA relationships demonstrate typ-
ical bifid morphology containing “A
loop” (demarcating atrial booster
pump function) and “V loop” (demar-
cating passive changes in LA pressure
and volume generated by LV activity).
End-systolic elastance was measured
for each chamber as the slope of the
line (demonstrated) comprised by con-
necting end-systolic points of the se-
ries of pressure–volume relationships
generated during inferior caval con-
striction.8 LA, Left atrial; Ees, end-sys-
tolic elastance.elastance, which assumed a linear fit to the progres-
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ETsion of data (Figure 2). Data derived in the stable
state were an average of 10 consecutive cardiac cy-
cles. Table 1 lists the indices of mechanical function
derived from pressure–volume data.
2. ICE: A commercial system was used (AcuNAV, Sie-
mens Medical Solutions, Malverne, Pa) that includes
a 10F deflectable catheter incorporating a phased-
array transducer with programmable operating fre-
quency.7 In the present study, this catheter was
placed as necessary into the right atrium and caval
veins, where it was rotated and deflected to achieve
the desired imaging planes. The imaging frequency
ranged between 5 and 7.5 mHz. The system is
ABLE 1. Data derived from pressure–volume analysis
Baseline
Afte
ab
V dP/dtmax (mm Hg/sec) 967 334 9
V stroke work (mL/mm Hg) 1317 896 11
V end-systolic elastance
slope*(mm Hg/mL)
4.9  3.4
V Tau†(ms) 28 6
A mean pressure (mm Hg) 5.9 4.1
A A loop area‡(mL/mm Hg) 28 22
A V loop area§(mL/mm Hg) 25 32
A end-systolic elastance slope
(mm Hg/mL)
0.61 0.25 0
A end-diastolic elastance slope
(mm Hg/mL)
0.31 0.25 0
aximum LA elastance: LV passive
stiffness ratio¶
0.99 0.94 0
A, Left atrium; LV, left ventricle. *A “load-independent” index of global LV
ctive (eg, delivery of energy derived from atrial myocyte contraction) work
rom LV contraction) work performed by the LA.8 A direct measure of pas
hat quantifies the relation between the contractile state of the LA and th
ABLE 2. Data derived from intracardiac echocardiograph
Baseline
After
abla
eak antegrade left pulmonary
vein flow velocity (m/sec)
1.2  0.4 1.4
eak retrograde left pulmonary
vein flow velocity (m/sec)
0.2  0.2 0.1
eak antegrade right pulmonary
vein flow velocity (m/sec)
1.1  0.2 0.9
eak retrograde right pulmonary
vein flow velocity (m/sec)
0.1  0.2 0.3
eak antegrade transmitral flow
velocity (m/sec)
2.6  0.5 2.8
itral regurgitant fraction (%) 3 1 1
eak atrial appendage contraction
wave velocity (m/sec)
0.5  0.2 0.1P  .05 versus baseline.
The Journal of Thoracicequipped with 2-dimensional imaging and pulsed,
continuous-wave, and color Doppler. In addition to
guiding placement and monitoring stability of pres-
sure–volume catheters (above), ICE was used to se-
rially assay atrial mechanical function using the in-
dices listed in Table 2,8-11 and to detect the presence
of intracavitary left-sided heart thrombi.
athologic Analysis
earts were first examined in situ to assess for damage to
oncardiac structures contiguous to the lesions. The heart
nd lungs were then removed en bloc. Gross visual inspec-
ion was performed from epicardial and endocardial van-
endage
only
After all ablation without
appendage occlusion
After all ablation with
appendage occlusion
304 878 193 848  122
780 1336 782 1403  852
2.5 3.0  2.1 3.2  3.5
8 29  7 30 8
4.0 5.8  3.7 7.1  4.3
16 15  10 38  43
52 19  9 34 17
0.17 0.59 0.26 0.52  0.22
0.51 0.41 0.13 0.50  0.23
0.92 0.84 0.64 1.08  0.82
LA8 contractility. †Time constant of LV isovolumic relaxation.20 ‡Indices of
rmed by the LA.8 §Indices of passive (eg, delivery of stored energy derived
A stiffness.8 ¶An index of mechanical “coupling” between the LA and LV
sive LV properties resisting its ejection.21
alysis
dage
nly
After all ablation without
appendage occlusion
After all ablation with
appendage occlusion
5 1.1  0.5 1.6  1.1
1 0.1  0.3 0.1  0.2
4 1.3  0.5 1.3  0.7
4 0.1  0.1 0.1  0.5
9 2.4  0.8 2.2  1.2
6  4 7  4
2* 0.1  0.1* 0r app
lation
75 
15 
3.8 
28 
6.2 
31 
38 
.38 
.49 
.75 
19 or 
 perfo
sive Lic an
appen
tion o
 0.
 0.
 0.
 0.
 0.
 1
 0.and Cardiovascular Surgery ● Volume 134, Number 4 985
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ETages. A particular interest was to assess the damage to the
itral valve apparatus and the appearance of the ablation
esion in coronary sinus tissue. Ablation lesions were ex-
mined to assess for evidence of charring or barotrauma.4
he heart was then immersed in 1% triphenyl tetrazolium
hloride for 60 minutes, after which atrial wall thickness
nd lesion dimensions (length, depth, and endocardial/epi-
ardial surface thicknesses) were measured.4 Histologic le-
ion transmurality was defined by exclusion of tetrazolium
tain spanning from endocardium to epicardium.
xperimental Protocol
ressure–volume and ICE data were acquired at each of 4
hases of the procedure: (1) baseline: after thoracotomy and
osterior mediastinal dissection, immediately before abla-
ion lesion deployment; (2) after LAA ablation only; (3)
fter all ablation; (4) after all ablation, with the appendage
ompletely occluded using a plastic clamp, confirmed by
CE. Each data set was acquired with the pericardial and
horacotomy edges reapposed and the lungs at functional
esidual capacity. Data sets 2, 3, and 4 were each acquired
fter 5 to 10 minutes of post-intervention steady state.
nalytic Methods
ata are reported as mean  standard deviation, unless
therwise specified. Within-animal differences in pressure–
olume and ICE indices between experimental stages were
ssessed for statistical significance using a Friedman repeat-
d-measures analysis of variance, followed by a Student–
ewman–Keuls multiple comparisons test.
esults
perative Notes
he cardiac rhythm was sinus throughout the procedure.
he baseline sinus cycle length (710  65 ms) did not
hange significantly during other phases of the experimental
rotocol. All animals were stable throughout the procedure,
ncluding systemic blood pressure, gas exchange, acid–base
tatus, electrolytes, and blood resistivity. During device
anipulation and ablation lesion application, we commonly
ABLE 3. Ablation and pathologic data
esion
Total energy delivered
in Joules
Durati
AA encircling 519 117
PV encircling 424 40
PV encircling 474 23
inear “a” 326 108
inear “b” 469 212
inear “c” 390 81
AA, Left atrial appendage; LPV, left pulmonary veins; RPV, right pulmonaerformed brief manual compression of the inferior caval e
86 The Journal of Thoracic and Cardiovascular Surgery ● Octoein to enhance LA flaccidity, which facilitated ablation
lectrode access/fixation and minimized blood loss. In 1
nimal, territory length necessitated that lesion B was per-
ormed with 2 contiguous applications; in all other animals
single application was sufficient. In 1 animal, 2 RF appli-
ations were necessary to achieve exit conduction block of
he LAA: Visual inspection after the first lesion revealed
hat the jaws of the device had been malpositioned, exclud-
ng a portion of tissue that presumably was the conduit
hrough which there was persistent conduction. After an
dditional application using a more appropriate device po-
ition, exit conduction block was demonstrated. In all ani-
als, exit conduction block was noted after single RF
pplications in both right and left pulmonary vein regions.
he entire experimental protocol was completed in all ani-
als in less than 30 minutes. Ablation data are summarized
n Table 3. No significant interlesional differences in abla-
ion energy requirement or duration were observed.
ssessment of Impact of Ablation on Mechanics
Pressure–volume. Relative to baseline, no significant
ifference was noted in any of the derived indices after
ppendage ablation alone or after all ablation with or with-
ut appendage occlusion (Table 1).
Intracardiac echocardiograph. Ablation did not alter
he morphology of the mitral leaflet. At no time was there
vidence of intracavitary thrombus. After appendage abla-
ion, spontaneous echo contrast was noted in the distal
ppendage region, suggestive of flow stasis. Relative to
aseline, no significant differences were noted in the trans-
enous or transmitral velocities after ablation. Similarly, the
itral regurgitant fraction was not significantly altered.
here was, however, a significant decrease in the peak atrial
ppendage contraction wave velocity after ablation of the
ppendage (Table 2).
athologic Analysis
t postmortem, there was no evidence of collateral damage
o cardiac or noncardiac structures. None of the lesions
application
conds
Lesion length in
centimeters
Lesion width in
millimeters
5 6.1  1.4 4.1  1.1
2 4.1  0.9 1.9  1.4
2 3.7  1.3 2.9  0.9
5 2.3  0.6 2.4  1.0
7 3.1  1.1 2.0  0.7
3 1.8  0.8 2.2  1.3
ins. Linear “a, b, and c” are indicated in Figure 1.on of
in se
18 
16 
17 
18 
17 
14 videnced thrombus or barotrauma (Figure 3). Lesion C
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ETbutted the posterior mitral leaflet, but there was no percep-
ible damage to the leaflet or contiguous chordal apparatus.
esion C also produced a transmural encircling lesion of the
ncluded coronary sinus musculature.
Ablation lesions were uniform and transmural through-
ut their course; the mean mural lesion thickness was 2.3 
.8 mm (range 1–6 mm) in regions of smooth endocardial
opography (pulmonary vein encircling lesions and linear
esions A and C) and 3.1  1.9 mm (range 1–8 mm) in
egions of trabeculated endocardial topography (appendage
ncircling lesion and linear lesion B). Individual lesion
imensions are summarized in Table 3.
iscussion
e used a method for LA ablation in a beating heart
ithout the need for cardiopulmonary bypass. Ablation was
erformed quickly and without complications, yielding ab-
ation/isolation of a relatively large territory of myocardi-
m.4,5 To assess the impact of the procedure on left-sided
eart mechanical function, we used pressure–volume and
chocardiographic analytic techniques in tandem. To our
nowledge, this is the first study to use pressure–volume
nalysis for this purpose; in addition, the simultaneous
cquisition of LA and LV data, which permits assay of
ndividual interchamber coupling, is also novel. Our data
onfirm our prior observation that this procedure did not
eem to adversely affect LA booster pump function.4,5 The
ata also extend these observations, demonstrating that ab-
ation did not seem to have an adverse affect on intrinsic LA
ontractility (elastance), passive LA mechanical properties
reservoir, conduit), LV systolic and diastolic mechanics, or
he vigor with which the LA and LV were mechanically
oupled.8
As we previously reported,4 the lack of adverse impact in
lobal indices of left-sided heart mechanical function dem-
nstrated here masked a potentially important regional di-
inishment in LAA function. Given that it was also ob- d
The Journal of Thoracicerved after appendage ablation but before ablation in the
emainder of the atrium, it is likely that this was primarily
he result of electrical isolation of appendage tissue, which
liminated its electromechanical activation. On the basis of
he echocardiographic features of the appendage after abla-
ion, including diminished flow and spontaneous echo con-
rast, we conclude as before that electrical isolation of the
ppendage without mechanical isolation would be unwise.4
ur data suggest that mechanical isolation would not ad-
ersely affect global left-sided heart mechanical function.
We note several important limitations to these data. First,
he experiment was performed in animals with healthy
earts and ablation was not performed concomitantly with
ther cardiac surgery. Abnormal cardiac structure and con-
omitant surgery are prominent in the human Maze experi-
nce. It is likely that preexisting atrial/ventricular dysfunc-
ion with or without concomitant surgery would have
ielded a different result. Also, as is true for any animal
xperiment, the applicability of these findings to humans is
naddressed. Second, assessment of LA mechanics using a
onductance technique has not been well studied. Of par-
icular concern is that spatially irregular, small-volume re-
ions such as the appendage may not be represented in the
onductance field or aggregate data. This concern is sup-
orted by the significant changes in LAA function demon-
trated by echocardiography. Third, our preparation in-
olved median sternotomy and pericardiotomy, which could
ave potentially masked adverse mechanical impact that
ould have been apparent in a closed-chest preparation.
ourth, our data are acute only and therefore do not address
he possibility of a delayed adverse impact on cardiac me-
hanics. Included in this consideration would be the possi-
ility that resulting intrinsic cardiac neurologic and/or hu-
eral perturbations could adversely affect mechanics.12 In
egard to this, in a chronic study using a similar animal
odel, Melby and colleagues13 demonstrated a significant
Figure 3. Photographs taken from en-
docardial vantage demonstrating typi-
cal lesion morphologies (post-tetrazo-
lium staining) in territories of smooth
(left) and trabeculated (right) endocar-
dial topography. RPV, Right pulmonary
vein.iminishment in LA motility at 1 month post ablation.
and Cardiovascular Surgery ● Volume 134, Number 4 987
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ETimilarly, it is important to note that acute lesion histology
ay not accurately portray chronic lesion histology; this
ould include an element of “healing.” Fifth, these data are
imited to the ablation paradigm (lesion pattern and ablation
ool) described here. Although we believe that an important
lement contributing to the lack of adverse mechanical
mpact was avoidance of damage to Bachmann’s Bundle,4
ur data do not address this issue or the impact of other
esion paradigms (left and/or right atrial), regardless of
hether they involve ablation in the region of Bachmann’s
undle. Sixth, our findings suggesting that appendage oc-
lusion would not significantly alter left-sided heart me-
hanics are in contrast with the findings of previous studies
n which significant alterations were noted.14-17 Possible
xplanations for this variance include the model, the thora-
otomy, the fact that the appendage was clamped but not
xcised, and the fact that the assessment was made only
fter all ablation lesions were deployed. Seventh, no effort
as made to assess the impact of the ablation procedure on
F inducibility/sustainability. Our goal was to assess the
mpact of ablation on left-sided heart mechanical function.
lthough we are dubious as to the clinical relevance of
rrhythmia suppression assessments in animal models, we
o note the high rate of AF suppression reported using a
esion set similar to ours in a canine model.18 Eighth, we
ote that our conclusions are derived from a small cohort
nd await prospective confirmation. Finally, it is important
o emphasize that although the tool used here is commer-
ially available, its use in human AF ablation is currently
ff-label (a clinical study intended to change the labeling is
ngoing). In addition, a specific contraindication is included
n the labeling for use in a “blood pool,” as was the case for
he lesions that necessitated atriotomy. As an additional
ote of caution, we remind readers that although we did not
bserve functional damage to the mitral apparatus after
nnular ablation, it has been reported elsewhere.13
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